Table 1:
Baseline Characteristics
| Characteristic | N=90 |
|---|---|
| Age, median (range) | 63.0 (34–83) |
| Gender, n (%) | |
| Male | 87 (97) |
| Female | 3 (3) |
| Tobacco hx, n (%) | |
| Never smoker | 39 (43) |
| <10 PY | 23 (26) |
| >10 PY | 28 (31) |
| Primary site, n (%) | |
| BOT | 48 (53) |
| Tonsil | 40 (44) |
| Soft palate | 1 (1) |
| Unknown | 1 (1) |
| Stage T, n (%) | |
| 1 | 19 (21) |
| 2 | 40 (44) |
| 3 | 20 (22) |
| 4 | 11 (12) |
| Stage N, n (%) | |
| 0 | 3 (3) |
| 1 | 2 (2) |
| 2a | 5 (6) |
| 2b | 63 (70) |
| 2c | 15 (17) |
| 3 | 2 (2) |
| ECOG PS, n (%) | |
| 0 | 76 (84) |
| 1 | 12 (13) |
| 2 | 2 (2) |
| P16 status, n (%) | |
| Positive | 90 (100) |
| HPV subtype, n (%) | |
| Not performed | 30 (33) |
| Performed | 60 (67) |
| HPV16 | 54 (88) |
| HPV33 | 3 (5) |
| HPV DNA not detected | 3 (5) |
| Risk category, n (%) | |
| Low | 44 (49) |
| High | 46 (51) |